Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)

Inclusion Criteria: * at least 12 years old, * had a history of SAR to ragweed pollen for at least one year * had a positive skin test (prick) to short ragweed allergen. * if female, had a negative urine pregnancy test (HCG) at the Screening Visit, and prior to treatment on the Treatment Visit * were non pregnant women of childbearing potential and used a medically acceptable, adequate form of birth control. Exclusion Criteria: * developed signs or symptoms of bronchospasm, i.e., wheezing, dyspnea, and/or cough, during the priming sessions; * had any significant medical condition which, in the judgment of the investigator, might interfere with the study or require treatment; * had an upper respiratory or sinus infection within two weeks prior to treatment; * had received escalating doses of immunotherapy, oral immunotherapy or short course (rush) immunotherapy for treatment of rhinitis; * were female subjects who were pregnant, breast feeding, or premenarchal; * could not adhere to concomitant medication prohibitions; * had a known potential for hypersensitivity, allergy, or idiosyncratic reaction to mometasone furoate nasal spray; * had asthma that requires systemic or inhaled corticosteroid treatment; * had large nasal polyps, marked septum deviations, or any other nasal structural abnormality that significantly interferes with nasal airflow; * had rhinitis medicamentosa; * had any relevant abnormal vital sign due to an unknown underlying disease and considered by the investigator and Sponsor Monitor to contraindicate study participation.